Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing tele-physiology: A chest patch solution for continuous, non-invasive remote monitoring in a hypoxic environment.

Experimental physiology·2026
Same author

Investigating Intraspecific Attacks in Brown Bears (<i>Ursus arctos</i>) Using a Forensic Approach: Evidence from Northern Italy.

Animals : an open access journal from MDPI·2026
Same author

Metabolism and respiration in skin burn injury in rats: Corrective effects of melatonin.

Respiratory physiology & neurobiology·2025
Same author

Differential response of taste perception to high-altitude exposure and ageing.

Appetite·2025
Same author

Volabolomics' innovative evidence technique could have changed the outcome of the 'painter murder' sentence?

Forensic science international·2025
Same author

Altered breathing pattern of lowlanders sleeping at high altitude: Novel insights from home sleep apnoea tests procedures.

Respiratory physiology & neurobiology·2025

Related Experiment Video

Updated: May 13, 2026

Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

Pathologies currently identified by exhaled biomarkers.

Andrea Mazzatenta1, Camillo Di Giulio, Mieczyslaw Pokorski

  • 1Unit of Sensory Physiology, Department of Neuroscience and Imaging, University of Chieti-Pescara G. d'Annunzio, Italy.

Respiratory Physiology & Neurobiology
|March 15, 2013
PubMed
Summary

Analyzing volatile breath biomarkers using metal oxide semiconductor (MOS) sensors offers a promising, non-invasive method for disease diagnosis. This technology aids in identifying conditions like diabetes and neurological fatigue.

More Related Videos

Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction
09:19

Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction

Published on: June 1, 2022

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

Related Experiment Videos

Last Updated: May 13, 2026

Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction
09:19

Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction

Published on: June 1, 2022

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Clinical Diagnostics

Background:

  • Ancient physicians recognized breath's diagnostic potential.
  • Volatile breath biomarkers indicate various diseases.
  • Challenges exist in identifying and quantifying these biomarkers.

Purpose of the Study:

  • Review clinical applications of metal oxide semiconductor (MOS) sensors for breath analysis.
  • Evaluate MOS sensors' ability to distinguish health from disease states.
  • Explore potential applications in diagnosing and managing specific conditions.

Main Methods:

  • Literature review of MOS sensor applications in breath analysis.
  • Discussion of challenges in analyzing low-concentration, small-volume breath samples.
  • Case examples including diabetes, multiple chemical sensitivity (MCS) syndrome, and central neural fatigue.

Main Results:

  • MOS sensors show potential for continuous breath analysis.
  • Successful differentiation between health and disease in specific conditions.
  • Demonstrated utility in detecting central neural fatigue from cognitive tasks.

Conclusions:

  • Exhaled breath analysis using MOS sensors is a promising diagnostic tool.
  • Potential applications in diagnosing and treating cognitive disorders associated with genetic or neurodegenerative diseases.
  • Further development needed for continuous, low-concentration sample analysis.